Cochlear Limited (ASX: COH) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Cochlear Limited Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Cochlear Limited (ASX: COH)
Latest News
Share Fallers
Cochlear Limited (ASX:COH) share price sinks lower on patent infringement news
Healthcare Shares
Why ResMed Inc. (ASX:RMD) is one of the best growth stocks on the ASX 200
Share Market News
Why this gold miner has skyrocketed 30% this month
Growth Shares
Is Blackmores Limited (ASX:BKL) share price headed to December '17 highs?
Share Gainers
Why the ResMed (ASX:RMD) share price is rallying to a 1-week high today
Growth Shares
3 healthcare shares to buy and hold for the next decade
Growth Shares
Where I would invest $25,000 in the share market
Healthcare Shares
Citi has just upgraded CSL Limited (ASX:CSL) to "buy"
Growth Shares
Is CSL Limited's (ASX:CSL) share price heading back above $200?
Share Market News
5 things to watch on the ASX on Wednesday
Share Market News
Should you buy shares valued to over $100 each?
Share Gainers
Cochlear Limited (ASX:COH) holds its AGM: Should you invest?
Frequently Asked Questions
-
Yes, Cochlear Ltd has historically paid two fully franked dividends a year.
-
Cochlear Ltd generally pays its dividends in April and October.
-
Cochlear Ltd listed on the ASX on 4 December 1995.
COH ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Cochlear Limited
Cochlear Ltd (ASX: COH) is the world's leading cochlear implant device manufacturer with around half of global market share.
The company was founded in Australia in 1983 to commercialise implants pioneered by Melbourne researcher Dr Graeme Clark, but later became a separate entity.
Developed markets contribute the bulk of Cochlear's group revenue with cochlear implants the standard of care for children with severe to profound hearing loss. The company is also catering for a growing cohort of seniors when standard hearing aid technology loses its effectiveness.
Cochlear's main products include cochlear implants, bone-anchored hearing devices, and associated sound processors. The vast majority of Cochlear's revenue is derived from overseas, with the US and Europe by far the company's two largest markets.
